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 ABBREVIATIONS 
 
The following abbreviations are used throughout this thesis: 
 
ABP – Arterial blood pressure 
ANOVA – Analysis of variance 
C:F ratio – Capillary to fibre ratio 
CD – Capillary density 
EC – Endothelial cells 
ECM – Extracellular matrix 
EDL – Extensor digitorum longus 
eNOS – Endothelial nitric oxide synthase 
FI – Fatigue index 
FMF – Femoral blood flow 
FVC – Femoral vascular conductance 
HIF – Hypoxia-inducible factors 
HR – Heart rate 
i.v. – Intravenous 
MABP – Mean arterial blood pressure 
MFA – Mean fibre area 
MFBF – Mean femoral blood flow 
MMP – Matrix metalloproteinase 
ns – Not significant  
s.c. – Subcutaneous 
S.E.M. – Standard error of mean 
TA – Tibialis anterior 
VEGF – Vascular endothelial growth factor 
 ABSTRACT 
The aim of this study was to elucidate whether two different types of angiogenic stimuli, known to elicit two 
fundamentally different types of angiogenesis in rat hindlimb skeletal muscle, produce an additive effect when 
applied simultaneously. When administered in drinking water, the α-1 adrenoreceptor antagonist, prazosin, 
elevates shear stress causing splitting angiogenesis in extensor digitorum longus (EDL) muscle; surgical 
extirpation of the tibialis anterior (TA) muscle, a synergist, induces sprouting angiogenesis in EDL muscle due 
to overload. We used an in vivo rat preparation to investigate how functional readouts of EDL muscle 
performance and hindlimb blood flow, upon indirect electrical stimulation of the common peroneal nerve, were 
changed, if at all, once these different types of angiogenesis had been induced. Muscle samples were analysed 
for structural changes and correlated with function changes, for each treatment group. 
Prazosin treated animals (2 week administration at 50 mg L-1) had EDL muscle that had no difference in 
capillary to fibre ratio (C:F ratio) to that in control animals, contrary to that found in the literature. Neither was 
there a change in muscle fatigue resistance for an isometric twitch contraction. Extirpated animals (allowed to 
recover 2 weeks post-operatively) had ipsilateral EDL muscle with an increase in C:F ratio relative to control 
animals, with a parallel increase in muscle fatigue resistance. Interestingly, combination treated animals 
(concurrently treated) had ipsilateral EDL muscle with an increase in C:F ratio relative to control animals, 
although with a lesser increase in C:F ratio than with extirpation alone. The muscle fatigue resistance was not 
significant when compared to control animals, like it was for extirpated animals. Both extirpated and 
combination treated animals had contralateral EDL muscles with no difference in C:F ratio or muscle fatigue 
resistance to that seen in control muscle. 
Prazosin administered animals (either prazosin treated or combination treated animals) maintained an elevated 
femoral artery vascular tone to that of non-prazosin administered animals (control and extirpated animals). 
Irrespective of treatment, no difference in vascular tone profile was discernible during muscle contraction. 
Thus, the key findings of this study were, that a supramaximal increase in capillary supply by prazosin 
administration, when there was no metabolic demand for such a change, did not correlate with a functional 
improvement in muscle fatigue resistance, although our data was confounded by the fact that this treatment did 
not induce an increase in C:F ratio, like that observed in the literature. Only surgical extirpation led to an 
increase in muscle fatigue resistance, achieved through a parallel increase in C:F ratio. Interestingly, when both 
stimuli were applied together, no additive increase in C:F ratio or muscle fatigue resistance was seen; moreover 
the structural and functional changes were less than that in animals that had undergone extirpation alone. Thus, 
there seems to be a feedback loop in place that prevents excessive angiogenic stimulation, a putative ‘angiogenic 
brake’, presumably to prevent signal transduction becoming pathological.  
When structural and functional data across treatment groups were aligned, it was C:F ratio and not vascular tone 
that correlated with fatigue index, for an isometric twitch contraction. Thus it seems that for muscle fatigue 
resistance, local diffusion is more important than global perfusion. 
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INTRODUCTION 
 
Angiogenesis: An overview 
Angiogenesis, not to be confused with de novo vasculogenesis, is the essential process by 
which new blood vessels grow, expand and integrate within an existing capillary network. 
This process is important physiologically during development and in tissue remodelling, 
where changes in the vascular bed supplying a tissue are needed in order to maintain tissue 
performance (Risau 1997). Angiogenic signalling however is perhaps most famous when 
aberrant, for example in tumour progression and metastasis, contributing to disease pathology 
in an array of cancers and related disease conditions (Folkman 1995). Such signalling is a 
constant coordination of multiple pro- and anti-angiogenic growth factors that cross-talk to 
form an integrated signalling meshwork, many of which have been implicated in tumour 
angiogenesis (Carmeliet and Jain 2000) and many of which have been targeted for anti-
angiogenesis therapy (O'Reilly et al. 1994; O'Reilly et al. 1997). The ‘balance’ of such 
signalling can lead to either physiological or pathological blood vessel growth (Ferrara 2001). 
Physiological angiogenesis is different to pathological angiogenesis in that it is controlled, 
non-excessive, growth that is necessary for a tissue to continue performing optimally (Ferrara 
2005). 
 
Chemical mediators of angiogenesis 
Whether resulting in pathological or physiological growth, growth factor signalling cascades 
are key to angiogenesis (Folkman and Klagsbrun 1987). The discovery of many of the pro- 
and anti-mitogenic regulators owes a lot to in vitro cell culture (Jain et al. 1997), from which 
important signalling molecules have been identified, along with their dependencies on other 
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signalling molecules. Cell culture assays use immortal cell lines, their growth being driven by 
excessive chemical signalling, like in cancers which are driven by mutations in important 
regulatory genes (i.e. oncogenes and / or tumour suppressor genes), a variety of which are 
reviewed here (Blume-Jensen and Hunter 2001; Vousden and Lu 2002). Such studies have 
helped elucidate many of the now well characterised angiogenic signalling processes, such as 
that of vascular endothelial growth factor (VEGF) and its family, which is considered the key 
player in all angiogenic remodelling (Hicklin and Ellis 2005). However, caution must be 
taken when applying what is known about a particular signalling axis, known to be important 
in pathological angiogenesis, to physiological angiogenesis. Whilst many regulators are 
common, there are likely many others uniquely altered in each specific pathology, meaning 
each pathology is differentially regulated depending on the combination of mutations present; 
therefore conclusions drawn are unlikely to be universally true for physiological remodelling 
(Seaman et al. 2007). The response to a physiological need to induce blood vessel growth, for 
example during exercise training, is a much more integrative response, not one born purely 
out of excessive, uncontrolled growth factor signalling to maintain a growing tumour mass 
(Egginton 2009). 
 
Angiogenic signalling pathways: Networks, redundancy and feedback 
The angiogenic response is a plastic process that reacts to demand in a tissue in a highly 
specific manner, whereby many signalling components are differentially regulated at the 
same time, to yield a net change that will be beneficial to the tissue; this process is kept in 
check by feedback control mechanisms. This network system must be rigidly controlled, both 
spatially and temporally, because the maintenance of any one signalling component at a non- 
optimal level may result in a pathological process, such as the ill-effects induced by the 
misregulation of placental soluble fms-like tyrosine kinase 1 (sFlt1) in preeclampsia 
P a g e  | 3 
 
(Maynard et al. 2003). There is much redundancy in both pro- and anti- angiogenic signalling 
molecules (Klagsbrun and D'Amore 1991), known from gene knockout studies and clinical 
trials aimed at targeting specific molecules using pharmaceutically modified antibodies. 
‘Anti-VEGF therapy’ involves the administration of a humanised monoclonal antibody called 
Bevacizumab (trade name: Avastin), which targets VEGF-A and successfully inhibits blood 
vessel growth, in a variety of cancers. The first treatment for which Bevacizumab was FDA 
approved for (although many clinical trials of Bevacizumab have since highlighted its 
efficacy, most recently for the treatment of age-related macular degeneration (Tufail et al. 
2010)) was for metastatic colorectal cancer, with the result being an extension in patient 
lifetime, although the cancer wasn’t actually cured (Ferrara et al. 2004). However, all too 
often when one member of a signalling network is inhibited in one way or another, another 
member of the pathway is up- or down-regulated to maintain angiogenic signalling, resulting 
in only temporary therapeutic benefit (Bergers and Hanahan 2008; Hicklin and Ellis 2005). 
 
Growth factor signals illicit changes in gene expression 
As eluded to, growth factors act as key signals in governing blood vessel growth. There are 
many growth factor families, including epidermal growth factor (EGF), fibroblast growth 
factor (FGF), platelet derived growth factor (PDGF) and vascular endothelial growth factor 
(VEGF), to name just a few (Coussens and Werb 2002). These factors when secreted bind 
receptors, known as receptor tyrosine kinases, located on the endothelial cell (EC) membrane, 
which transduce the signal into the cell; this initiates a molecular cascade within the cell that 
results in changes in gene expression (Adams and Alitalo 2007). Each growth factor has its 
own cognate receptor, which induces specific gene expression changes. The net result of the 
various signalling components is angiogenesis; individual pathways have now been 
elucidated, aiding our understanding of blood vessel growth.  
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VEGF signalling at the EC interface, is the best characterised of the angiogenic signalling 
components (Ferrara 2001), such that the signalling of two different VEGF receptor subtypes, 
VEGFR-1 (aka Flt-1 [fms-like tyrosine kinase]) (de Vries et al. 1992) and VEGFR-2 (aka 
Flk-1/KDR [kinase domain region]) (Terman et al. 1992), have been characterised. Both 
types of VEGF signalling are essential during embryonic development, in evidence by gene 
targeting studies that induced embryonic lethality in mice (Fong et al. 1995; Shalaby et al. 
1995). Once these mice were born, postnatal development was similarly inhibited by Cre-
loxP-mediated gene targeting, with the result being increased mortality, stunted body growth 
and impaired organ development (Gerber et al. 1999; Kuhn et al. 1995), although beyond 4 
weeks of life, VEGF block had less detrimental effects to the animal. The presence of two 
subtypes of VEGF receptor is rather elegant. The two have different signal transduction 
profiles; VEGF-dependent tyrosine phosphorylation of Flk-1/KDR induces mitogenesis, 
while VEGF binding to Flt-1 does not produce a detectable response (Waltenberger et al. 
1994). It was hypothesised that Flt-1 acts as a ‘decoy’ non-signalling receptor, regulating 
VEGF signalling via Flk-1/KDR by sequestering the ligand from its signalling receptor; this 
inhibition achieved by the ‘decoy’ receptor is only overcome when saturating concentrations 
of ligand are present (Park et al. 1994). 
 
The knockout of VEGF was effective as signalling via the VEGF receptors on the EC 
membrane was inhibited; when knockout doesn’t occur the net result is endothelial growth, 
resulting in new blood vessels. However, vital to this process is the presence of signals from 
other characterised ‘support’ cells surrounding the endothelium, such as pericytes (Raza, 
Franklin, Dudek 2010). This is achieved by reciprocal paracrine signalling between ECs and 
pericytes (summarised in Fig. 1). ECs release PDGF, creating a concentration gradient that 
causes the recruitment of pericytes local to the ECs (Gerhardt et al. 2003). The binding of 
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PDGF to its receptor (PDGFR) on the pericyte cell membrane causes signal transduction, 
resulting in stimulation of the MAPK/ Erk1/2 signalling axis, the net result being pericyte 
proliferation, ensuring endothelial growth is sufficiently supported and guided (Carmeliet 
2003). Pericytes also secrete VEGF, which signal via the VEGFR-2 receptor on the EC 
membrane, initiating the PI3K/ Akt signalling axis (Gerber et al. 1998); the net result of this 
is EC survival, promoted by anti-apoptotic proteins Bcl-2 and A1 with pro-survival activities 
(Gerber, Dixit, Ferrara 1998). Other growth factors (for example, FGF and TGF) signal at the 
EC interface via their own specific receptors, triggering tyrosine kinase induced 
phosphorylation of downstream transcription factors, with the net result being the promotion 
of EC proliferation and their migration (Adams and Alitalo 2007). Another class of tyrosine 
kinases characterised in angiogenic processes are Tie1 and Tie2, which are specifically 
expressed on ECs (Sato et al. 1995). The Tie2 receptor was proven to be important in 
angiogenesis, as when it was lacking, angiogenic defects in endothelial-matrix contact were 
presented; similar defects were evident when its ligand Angiopoietin-1 (Ang-1) was lacking 
(Suri et al. 1996). Angiopoietin-2 (Ang-2), an antagonist for Ang-1 at Tie2, disrupts 
signalling through this receptor, hindering effective blood vessel growth (Maisonpierre et al. 
1997), again highlighting the exquisite regulation present in angiogenic signalling. Cellular 
adhesion molecules, at the cell membrane, are also vital to achieving angiogenesis. The 
PECAM-1/CD31 molecule, is known to be important in mediating EC-EC contact when 
forming tubes that later become patent blood vessels. When these contacts were blocked by 
specific antibody, new blood vessels could not be induced (DeLisser et al. 1997). Other non-
growth factor like regulators are also vital to angiogenic processes, for example extracellular 
matrix (ECM) proteases are secreted prior to EC migration, to degrade the ECM and free 
space to allow for the new capillary growth (van Hinsbergh and Koolwijk 2008). The panel 
of angiogenesis-inducing molecules are required in both a spatially and temporally specific 
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order to produce a viable stimulus for blood vessel growth. Without concurrent signalling, by 
both ECs, pericytes and other surrounding tissues, gene expression of survival, proliferation 
and migratory components will not maintain capillary growth through to competency 
(Gerhardt and Betsholtz 2003). Therefore, it is important that a coordinated suite of responses 
are present to regulate and support angiogenesis. Thus for angiogenesis, whether it is induced 
by tumour growth, tissue damage (i.e. wound healing), inflammation or by exercise, there is a 
lot of cross over in components activated. In tumour biology it is very daunting to attempt to 
develop a master-inhibitor of angiogenesis due to the sheer number of targets prone for 
potential manipulation. Similar scope of angiogenesis knowledge is needed in the 
physiological angiogenesis research field. 
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Fig 1: Schematic giving a brief overview of angiogenic signalling processes initiated at the cell membrane of an 
EC. Growth factor ligands bind their specific cognate receptors that span the membrane of ECs, which initiates a 
molecular cascade within the cell. This cascade causes modulation of multiple downstream components, often 
recruiting many hundred individual components, the net result being a change in gene expression, helping to 
support angiogenesis. For example, VEGF secreted by recruited pericytes initiates the PI3K-Akt signalling axis 
via VEGFR2 at the EC membrane, promoting survival. Concurrently, PDGF secreted by the EC triggers Erk1/2 
signalling via PDGFR at the pericyte cell membrane, resulting in its proliferation. Other growth factor signalling 
families will similarly have their signal transduced across the cell membrane upon binding to their receptors on 
the EC, stimulating its migration and proliferation. Once MMPs have been recruited (signalled as part of the 
mass of gene expression changes) causing ECM remodelling, angiogenesis can then occur in the now free space. 
This whole physiological process is stimulated by an initial change in the local environment, for example 
hypoxia as a result of exercise (or indeed pathologically at the centre of a malignant tumour). 
 
 
 
 
Physiological angiogenesis: Blood vessel growth in skeletal muscle 
In physiological angiogenesis, particularly in the field of exercise physiology, the aim is not 
to inhibit but to induce blood vessel remodelling. Naturally, there are many ways to optimise 
exercise performance, encompassing almost every organ system. Central adaptations, 
stimulated by exercise, include cardiac enlargement and arteriogenesis of conduit vessels, 
while peripheral adaptations, include switching of skeletal muscle phenotype (improving 
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strength, for example in weight lifters), angiogenic remodelling of the capillary bed supplying 
the muscle (improving fatigue resistance, for example in cyclists and swimmers) and a 
combination of these adaptations, if the specific nature of the exercise training stimulates 
both such changes (Holloszy and Booth 1976). If the stimuli are extreme enough these can 
occur quite independently of one another, but most exercise co-induces multiple adaptations 
at the same time, albeit over different time scales. Exercise training induced changes often 
include co-adaptations that bring about an alignment between the vasculature and cellular 
respiration systems, thus enabling the support of the observed improved muscle performance. 
For example, in endurance exercise training (aerobic distance running but not strength 
training), exercise induces an increased muscle endurance response, with proportional 
increase in mitochondrial electron transport chain capacity (Robinson et al. 1994). Such 
changes within the muscle fibres occur after the increases in capillarity (Skorjanc et al. 1998), 
meaning muscle activity efficiency, once both adaptations have occurred, is maximised. 
Changes in the vasculature system supplying an exercising muscle, whether it be via bulk 
blood flow (gross perfusion) or the specific capillary network (local diffusion path length to 
the respiring tissue), optimise the delivery of nutrients to and removal of waste material from 
the muscle, allowing for continuing activity and the maintenance of optimal performance 
(Hudlicka, Brown, Egginton 1992). From here on in the only physiological adaptation of 
skeletal muscle of interest, is the plastic process of angiogenesis. 
 
Mechanotransduction of the angiogenic signal 
The chemical signalling milieu that induces blood vessel growth can also be manipulated 
upstream by important, though far less characterised mechanical influences (Hudlicka, 
Brown, Egginton 1992). Haemodynamic forces and physical deformation at the muscle-
capillary interface are rather potent stimuli for vascular remodelling, such signalling feeding 
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into downstream chemical counterparts, the roles of which are better characterised. There are 
three examples of such factors; elevated shear stress caused by functional hyperaemia acting 
directly on the luminal surface of ECs, wall tension caused by blood pressure in exercising 
tissue, and stretch/ deformation of tissue acting on the abluminal surface of the vasculature 
(Egginton et al. 2001). These stimuli alter the local physical environment, i.e. the ECs, 
vascular smooth muscle, the ECM and other surrounding non-endothelial support cells like 
pericytes, which cause mechanotransduction of the signal via the host of kinases, causing an 
integrative angiogenic response (Egginton 2011). The investigation of mechanical, rather 
than chemical, influences on angiogenesis by examining the co-ordinated suite of responses 
observed when applying such stimuli, have led to the realisation of just how important a role 
such factors are in driving the process of in vivo capillary growth. 
 
Exercise models of angiogenesis 
Exercise models of angiogenesis are the best way to study the gross integrated response to 
angiogenic stimulation and are most relevant to exercise physiology. Such studies yield 
information about the adaptations made by certain types (e.g. treadmill running) and 
intensities (low to high) of exercise training, in a particular species (rats, dogs and humans 
are regularly used) over time, although the variation in the literature often confounds the field 
when attempting to make comparisons (Egginton 2009). These exercise-training studies 
typically assess exercise performance as well as assaying a selection of genomic transcripts 
and proteins (of various pro- and anti- angiogenic factors) to attempt to elucidate what 
underlies the exercise-induced changes, although care must be taken, as genomic and 
proteomic responses often do not change in parallel (Milkiewicz et al. 2006)). 
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It has been shown that stimulation of angiogenesis may result in the release of growth factors 
such as VEGF, as levels of these factors increased in rat skeletal muscle during a single bout 
of dynamic exercise; such changes have also been shown by indirect electrical stimulation 
(Hang et al. 1995). This increase in VEGF after exercise decreases within a few hours to 
resting levels and is not sustained with further exercise bouts (Gavin and Wagner 2001). It 
was shown that VEGF is important both for basal capillarity and in the angiogenic response 
in skeletal muscle upon exercise, by elegant VEGF Cre-loxP skeletal muscle conditional 
knockout experiments (Wagner et al. 2006). The knockout decreased VEGF levels and 
capillarity within skeletal muscle, highlighting how essential VEGF is to angiogenic 
processes. In these knockout animals, the baseline capillary to fibre ratio (C:F ratio) was 
decreased, impairing the performance in these animals relative to controls; furthermore no 
increase in C:F ratio or endurance capacity could be induced upon treadmill training, unlike 
matched-controls who had increased C:F ratios and could run faster for longer (Olfert et al. 
2009). This highlights how important VEGF and the C:F ratio is for muscle performance, 
both in capillary maintenance and during angiogenesis. 
 
Similar studies have indicated the importance of endogenous anti-angiogenic factors, as well 
as the pro-angiogenic ones. It was shown that during exercise, the anti-angiogenic factor, 
thrombospondin-1 was also increased during exercise in rats skeletal muscle (Olfert et al. 
2006), just like VEGF was (Breen et al. 1996). Upon repeated exercise bouts to train the 
animals, the ratio between pro- and anti-angiogenic mRNA transcripts (the balance) shifted 
so pro-angiogenic factors were upregulated, relative to anti-angiogenic factors which were 
rather downregulated, which was correlated with adaptive remodelling of capillaries (Gavin 
and Wagner 2001; Olfert et al. 2006). Interestingly, in the short-term, the response to exercise 
showed an increase in thrombospondin-1 levels; as further training occurred, the 
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thrombospondin-1 levels decreased, until long-term experiments where they were increased 
once more (Olfert et al. 2006). It seems that thrombospondin-1 is a switch that is induced 
with mitogens such as VEGF when exercising; they are co-expressed at a similar level 
initially. When angiogenesis is required, its levels are downregulated, until after training 
when sufficient blood vessel growth has occurred and it is upregulated once more to inhibit 
further angiogenic signalling. This regulation between pro- and anti-angiogenic factors, the 
VEGF-thrombospondin-1 axis (and others no doubt), is rather elegant and explains the 
exquisite control demonstrated in effective physiological angiogenesis. 
 
Other research groups have examined vascular remodelling in human skeletal muscle, 
attempting to elucidate the mechanisms behind exercise-induced changes. Muscle biopsy 
post-exercise in one study, revealed that changes in VEGF mRNA were proportional to 
changes in hypoxia-inducible factor (HIF-1α and HIF-1β) mRNA; these changes in 
expression occurring in a graded manner based on the level of metabolic stress. Thus, HIF 
seems to be able to regulate angiogenic factors during exercise too (Gustafsson et al. 1999).  
 
Exercise models of angiogenesis are useful when investigating the integrated angiogenic 
response to exercise-derived stimuli. However, as the ‘exercise cycle’ induces a whole host 
of changes, in order to attempt to clearly elucidate the mechanism of an individual 
mechanical activity on the integrated web of chemical components, various angiogenesis 
models have been developed, aiming to replicate a single individual component at a time 
(Egginton et al. 2001). Three of these are discussed. 
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Chronic electrical stimulation 
Chronic electrical stimulation of animal muscles via implanted electrodes, has been used to 
induce exercise-like adaptations. Stimulation in the rat hindlimb, induced an increase in C:F 
ratio in extensor digitorum longus (EDL) muscle, within a few days, relative to control 
animals. “The complex pattern of vessels underwent remodelling between 2 and 7 days of 
stimulation, resulting in more tortuous capillaries with numerous sprouts and loops”; such 
changes correlated with basement membrane disruption around the endothelium. It was 
postulated that a combination of types of angiogenesis were occurring as a result of the 
stimulation regime (Hansen-Smith, Hudlicka, Egginton 1996). Further study of chronically 
stimulated muscle revealed that the length of stimulation duration was related to the degree of 
disruption of the endothelial glycocalyx layer of capillaries, a mechanism by which 
angiogenic stimuli are mechanotranduced within the endothelium (Brown et al. 1996). The 
importance of basement membrane disruption in capillary growth was confirmed by 
inhibition of matrix metalloproteinases (MMPs); this resulted in no new capillary growth as 
basement membrane proteolysis was no longer performed (Haas et al. 2000). By stimulating 
muscle in this manner, an integrative response was induced, just like in normal exercise; in 
order to elucidate the role of these individual components, simpler models were devised. 
 
Shear stress and splitting angiogenesis 
An elevated shear stress component was known to act on the endothelium, causing an 
observable increase in muscle C:F ratio (Zhou et al. 1998a). The muscle hyperaemia was 
thought to disrupt the glycocalyx meshing the endothelium and surrounding ECM together, 
initiating mechanotransduction (Brown et al. 1996). The luminal surface was disrupted and 
cytoplasmic processes observed. This was a distinct type of capillary growth known as 
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splitting angiogenesis, which proceeds by longitudinal splitting of the parent vessel, by 
filopodial extension along the centre, forming two daughter vessels (Zhou et al. 1998a). A 
number of key signalling components, many of which are known to be key mediators of 
changes in endothelial cell morphology (e.g. neuropilin, midkine and restin), have been 
shown to activated in splitting angiogenesis (Williams et al. 2006c). Of the other upregulated 
components, some are unique to this type of angiogenesis (e.g. endothelial nitric oxide 
synthase (eNOS)) (Williams et al. 2006b) and others are common to all types of angiogenesis 
(e.g. VEGF, Flk-1, angiopoietin-2 and PECAM-1) (Williams et al. 2006a; Williams et al. 
2006c). Splitting angiogenesis can be induced experimentally by the administration of the 
drug prazosin, an α-1 adrenoreceptor antagonist dissolved in drinking water. This produces 
predominantly skeletal muscle hyperaemia, with minimal systemic effects. Significant 
angiogenesis can be seen in rat skeletal muscle of the hindlimb within 2 weeks via this means 
(Zhou et al. 1998a). Induction of shear stress in in vitro endothelial culture has been shown to 
elicit graded changes in expression of genes related to endothelial migration, proportional to 
the grade of shear stress applied (Sheikh et al. 2003). Traditionally, one dose of prazosin (50 
mg L-1) (Egginton et al. 2001) has been administered in vivo, but theoretically, different 
degrees of shear stress could be investigated by changing the dose administered. 
 
Overload and sprouting angiogenesis 
The muscle stretch or overload component was known to cause changes in ECM structure, 
allowing for vasculature remodelling, resulting in an increase in muscle C:F ratio (Zhou et al. 
1998b). This stretch of muscle causes endothelial cells to be strained; these cells 
mechanotransduce the signal inducing a plethora of changes in growth factor signalling, the 
result being the proliferation of the endothelium (Chang et al. 2003; Yamaguchi et al. 2002; 
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Zheng et al. 2001). The abluminal surface was disrupted and cytoplasmic processes observed. 
This was a distinct type of capillary growth known as sprouting angiogenesis, which originate 
as lamellipodial sprouts off the parent vessel (Zhou et al. 1998b). A number of key signalling 
components, many of which are known to be key mediators of endothelial cell migration and 
capillary tube formation (e.g. matrix metalloproteinase 2 (MMP-2), TIMP, SPARC and 
thrombospondin), have been shown to be activated in sprouting angiogenesis (Williams et al. 
2006c). Of the other upregulated components, some are unique to this type of angiogenesis 
(e.g. MMP-2) (Rivilis et al. 2002) and others are common to all types of angiogenesis (e.g. 
VEGF, Flk-1, angiopoietin-2 and PECAM-1) (Williams et al. 2006a; Williams et al. 2006c). 
Sprouting angiogenesis can be induced experimentally in muscle by surgical extirpation of a 
synergist muscle; for example removal of the tibialis anterior (TA), causes overload 
(compensatory hypertrophy) in the EDL during a 2 week recovery period. Significant 
angiogenesis can be induced in rat skeletal muscle of the hindlimb within 2 weeks via this 
means (Zhou et al. 1998b). Different grades of muscle overload have been investigated in 
vivo based on the degree of surgical ablation performed; data suggests that the response is a 
graded, not threshold process (Egginton et al. 2011). 
 
The potential of angiotherapy 
 
Angiotherapy is the broad description given to the approach whereby blood vessel growth is 
the target of intervention, in a variety of normal and abnormal disease processes. By 
identifying, characterising and understanding the underlying physiological components of 
blood vessel growth and how pathology is generated by these components, researchers aim to 
modify the aspects of angiogenesis thought to be amenable to specific modulation, to a 
therapeutic end (Ferrara and Kerbel 2005). Effective angiotherapy may not be achieved via a 
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single intervention; thus angiotherapies may need to be concurrently applied at blood vessel 
differentiation, maintenance and/ or homeostasis processes (Carmeliet and Jain 2000). 
Angiotherapy can either be angio-inhibitory (i.e. in the control of tumour growth) or angio-
stimulatory (i.e. in stimulating muscle blood vessel growth to aid exercise performance). New 
developments in the angiogenesis field will be of interest to those looking to develop 
angiotherapies, whether they be cancer researchers or exercise physiologists. Exercise 
physiologists may well be interested in the angiogenic changes induced by prazosin 
administration and by surgical extirpation, and the impact these types of angiogenesis have 
on muscle performance. Should any improvements in muscle performance be identified, then 
the work could be bought into the clinic to provide benefit to patients. 
 
Combinational therapy? 
As different mechanical stimuli are known to elicit fundamentally different types of 
physiological angiogenesis (Egginton 2011), it is of current interest whether two of these 
stimuli could be simultaneously applied to give additive capillary growth (Fig. 2). Could both 
types of angiogenesis induced be applied concurrently to give an optimal capillary structure 
within a muscle? Could such a structure, functionally be able to perform better for longer? 
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Fig 2: Schematic highlighting different mechanical stimuli that could be used to induce angiogenesis in EDL 
muscle. Prazosin administration, known to cause enhanced shear stress (red arrow) and wall tension (green 
arrow) and surgical extirpation causing muscle overload (blue arrow), induce splitting and sprouting 
angiogenesis, respectively. It is of interest whether additive changes in the capillary bed supplying a skeletal 
muscle could be induced by applying both stimuli. 
 
Evidence has suggested that chronic electrical stimulation of muscle has resulted in both 
splitting and sprouting forms of angiogenic growth (Hansen-Smith, Hudlicka, Egginton 
1996), raising the possibility that these distinct mechanisms may be additive. In vivo 
physiological angiogenesis has been shown to occur in a graded manner based on stimulus 
intensity, meaning a stronger stimuli yields a stronger response (Egginton et al. 2011). Thus, 
a preliminary study aimed to apply both shear stress and overload stimuli in combination, to 
examine whether an additive effect could be induced (Olgaard et al. 2008).  
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The rat EDL, a skeletal muscle of the hindlimb, is a mixed muscle of approximately equal 
glycolytic and oxidative fibre content, with a proportional blood flow to the rest of the 
hindlimb muscles (Armstrong and Laughlin 1983). Thus, it is a suitably representative 
candidate muscle in which to study angiogenesis and has been traditionally used for many 
years (Hudlicka, Brown, Egginton 1992). Indeed, it was the EDL that was studied by Olgaard 
et al. (2008).  
 
Preliminary data from stained muscle sections and Western blots of key biochemical proteins 
assayed from EDL, indicated that an additive angiogenesis (in either capillary number or in 
VEGF or eNOS content) cannot be achieved when prazosin drinking water is administered 
for 2 weeks, alongside unilateral extirpation of the synergist TA muscle, also for 2 weeks. It 
is hypothesised, that during 2 weeks of simultaneous co-stimulation, that muscle overload is a 
maximal stimulus for angiogenesis and so the additional shear stress stimuli is essentially 
supramaximal, explaining why it elicits no further capillary growth (Olgaard et al. 2008). 
 
Aims 
The aim of this study was to investigate the response to these fundamentally distinct types of 
angiogenic stimuli (which are both induced simultaneously by exercise), applied additively in 
rat skeletal muscle. Our rationale, was to examine the correlation (if any) between structural 
and functional data, so to have statistically robust, powerful data that would hopefully reveal 
to what extent structural adaptation drives functional capability. For example, when subjected 
to the two distinct types of angiogenic remodelling stimuli to induce changes in muscle 
architecture (measures of C:F ratio, capillary density (CD) and mean fibre area (MFA), in a 
given muscle section), would different functional performance characteristics (muscle tension 
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and fatigue during contraction and hindlimb blood flow) be observed? Would these putative 
changes occur in a linear or non-linear fashion? When the different angiogenic signalling 
pathways applied in combination give an additive effect? Such data would be of particular 
interest in the physiological angiogenesis field, where it is unclear whether different 
angiogenic stimuli induce unique performance-based adaptations. Our approach was to use an 
in vivo rat preparation to derive the functional data. Then, once the animal was sacrificed, the 
muscle was sampled and structural data assessed. Structure and function relationships could 
then be assessed and the hypothesis proposed in Olgaard et al. (2008), investigated. 
Establishing whether angiogenesis is a true graded phenomenon, is an important step in 
designing better targeted treatments for patients. 
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METHOD DEVELOPMENT 
 
To determine the functional capabilities of a skeletal muscle in the rat hind limb, an in vivo 
setup was designed in order to elucidate the whole-animal integrative response to 
physiological angiogenesis. The aim was to measure bilateral hindlimb blood flow (as a 
surrogate for EDL muscle blood flow) using perivascular flow probes positioned around the 
femoral arteries, upon stimulation of the common peroneal nerve to elicit EDL muscle 
contraction. A force transducer was used to measure developed tension and fatigue. The aim 
was to discover whether these variables differed in EDL muscle that had undergone different 
types of angiogenesis. 
 
The original aim was to stimulate bilaterally and record tension in both hindlimbs using two 
force transducers. The rewiring of two Grass force transducers was attempted, however a 
stable signal was never obtained, preventing construction of an adequate calibration curve. 
Thus unilateral measurement was settled upon, making use of one alternative working force 
transducer. The calibration curve for this force transducer is given (Fig. 3), showing operation 
at the linear (i.e. most accurate) part of its dynamic range. 
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Fig 3: Calibration curve for ADI force transducer showing the accuracy of the force recorded, when a series of 
known weights (National Physics Laboratory Standards) were applied. The observed range during all 
experiments was between ~ 0.30-1.20 N, corresponding with the linear section of the calibration curve (r2 = 
0.99). 
 
 
In order to optimise experimental protocols, the literature was searched to see what other 
groups had done, then a technique was refined to maximise sensitivity and minimise 
variability. The general animal setup decided upon was similar to that used by (Egginton et 
al. 1998; Ray and Marshall 2009a; Ray and Marshall 2009b). After practising the surgery on 
a number of cadavers, preparation in living animals began, to further improve surgical 
competency and technique, and to get used to maintaining a constant depth of Alfaxan-
anaesthesia throughout the duration of the experiment. During these preliminary experiments 
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a final protocol was refined until robust; this was then used in all subsequent animals, across 
each of the treatment groups. 
 
The setup in brief (detailed in ‘Materials and Methods’), consisted of a supine rat 
anaesthetised with Alfaxan via a jugular vein cannula. A tracheotomy was performed to help 
maintain a patent airway. The brachial artery was cannulated in order to record mean arterial 
blood pressure (MABP; mmHg) from which heart rate (HR; BPM) was derived. Both femoral 
arteries were isolated and flow probes positioned to extrapolate bilateral femoral blood flow 
(FBF; ml min-1). From this, femoral vascular conductance (FVC; ml min-1 mmHg-1) was 
derived by dividing FBF by MABP. The ipsilateral common peroneal nerve was isolated and 
sectioned at the proximal end; an electrode was positioned beneath the nerve in order to 
provide electrical stimulation. The ipsilateral EDL muscle was isolated and sectioned at the 
distal end and attached to a force transducer (although for ease, both the TA and EDL 
muscles were assayed in early preliminary experiments) to measure tension generated upon 
electrical stimulation, from which fatiguability could be calculated. Data was recording in 
real-time on LabChart; an example of a trace is given (Fig. 4). 
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Fig 4: Raw trace from LabChart, for a preliminary experiment. 
The trace shows a 10 Hz stimulation of the combined TA and EDL muscles, in Alfaxan-anaesthetised male 
Wistar rats. Contractions achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 
V, 5 min [indicated by the black bar]) of the intact common peroneal nerve. The seven channels show the 
continuous, real-time measurement of the labelled variables. Notice the presence of a central response in HR 
(channel 3), the smooth decay in tension generated (channel 5) and the response in FBF and FVC to stimulation. 
Channels 4, 6 & 7 show hyperaemia due to femoral artery vasodilatation. The tension generated during the 5 
minute stimulation period, was used to calculate a score of muscle fatiguability that could later be compared 
across animal treatment groups. 
  
 
A number of stimulation frequencies were assayed, to replicate different intensities of muscle 
activity (i.e. 4, 10 & 40 Hz, akin to different intensities of exercise). A stimulation time of 5 
minutes was used as previously (Egginton et al. 1998; Ray and Marshall 2009a; Ray and 
Marshall 2009b). Time trials indicated that there was no significant change in blood flow or 
tension generated beyond 5 minutes of stimulation (data not shown), and nothing was 
observed during preliminary experiments to indicate otherwise. Based on previous experience 
in the laboratory, MABP and HR data were consistent to other Alfaxan-anaesthetised 
1 - ABP (mmHg) 
2 - MABP (mmHg) 
3 - HR (BPM) 
 
6 - Ipsi MFBF (ml min-1) 
7 - Ipsi FVC  
     (ml min-1 mmHg-1) 
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preparations (Ray and Marshall 2009a; Ray and Marshall 2009b). Importantly, electrical 
stimulation of the common peroneal nerve elicited no significant central response in MABP 
by the ‘end’ of the stimulation period (not significant (ns) vs. ‘rest’, Student’s t-test, n = 7; 
Fig. 5a) regardless of stimulation frequency, but there was evidence of full body twitch, 
suggesting there was some systemic central response produced. This was in evidence by the 
significant central response in HR by the ‘end’ of the stimulation period (P < 0.05 vs. ‘rest’, 
Student’s t-test, n = 7; Fig. 5b and Fig. 4), for 4 and 10 Hz stimulation frequencies. Such 
twitching may also have contributed and thus caused inaccurate tension recordings. Therefore 
it was decided that the main experiments would be conducted with a cut common peroneal 
nerve to avoid such afferent feedback. Central responses in MABP or HR were eliminated in 
all subsequent experiments (data not shown). Furthermore, such treatment of a nerve has 
been shown to give a stable preparation, for up to 5 bouts of stimulation, for the sciatic nerve 
(Ray and Marshall 2009a; Ray and Marshall 2009b); the cut common peroneal nerve was 
found to be just as stable. 
 
To emulate different types of exercise-induced muscle activity, we compared high and low 
stimulation frequencies, simulating different intensities of exercise. Preliminary data showed 
that there was a significant increase in blood flow by the ‘end’ of the stimulation period, 
regardless of stimulation frequency (P < 0.05 vs. ‘rest’, Student’s t-test, n = 7; Fig. 5c) which 
was matched by a significant increase in vascular conductance by the ‘end’ of the stimulation 
period, for every stimulation frequency except 4 Hz (P < 0.05 vs. ‘rest’, Student’s t-test, n = 
7; Fig. 5d). The greatest dynamic range in blood flow and vascular conductance was seen at 
10 Hz, and was therefore used as the stimulation frequency for all subsequent experiments. 
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Fig 5: Integrative response to isometric muscle contraction. 
A-D show mean (±S.E.M. error bars, n = 7) MABP, HR, MFBF and FVC for 4, 10 and 40 Hz stimulations of 
combined TA and EDL muscle, at 4 different time points, in Alfaxan-anaesthetised male Wistar rats. 
Contractions achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of 
the intact common peroneal nerve. * P < 0.05 vs. ‘rest’ (Student’s t-test). There was no significant difference in 
MABP, HR, MFBF or FVC at any time point between different stimulation bouts. 
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To establish muscle tension fatigue upon stimulation, we initially tested combined TA and 
EDL fatiguability, which was expressed as fatigue index (FI), derived by dividing the ‘end’ 
tension by the ‘initial’ tension. This established the expected greater FI at high versus low 
stimulation frequencies, in control animals (data not shown). The intention was to assess the 
capabilities of animals that had undergone different angiogenic treatments, some of which 
would have had surgery to remove the TA. Thus, to ensure consistency between groups, we 
examined the influence of TA presence (because in treatment groups where animals have 
undergone TA removal, there was no TA present to confound what was been measured for 
the EDL alone). On retraction of the TA, there was no smooth decay in tension, and 
depending upon the force and angle of retraction, the apparent influence on EDL FI was 
variable (large standard error of mean (S.E.M.); data not shown). Thus, removal of the TA 
required some refinement, as initially nerve damage led to muscle weakness; this however 
was overcome upon practice. Although removal of the TA increased surgical intervention, 
doing so permitted comparison of blood flow and tension data, and meant that regardless of 
the treatment group, the setup and protocol was kept as constant as possible (assaying the 
EDL only, in every case), without confounding the data collected. For the EDL alone, the FI 
was much more consistent for a given stimulation frequency (indicated by small S.E.M.), 
regardless of the treatment applied. For all stimulation frequencies, there was a significant 
decay in tension by the ‘end’ of stimulation (P <0.01 vs. ‘initial’, Student’s t-test, n = 7; Fig. 
6a). The FI was significantly different for each stimulation frequency (P<0.05 vs. other 
stimulation frequencies, between treatments ANOVA with Scheffé Post hoc test, n = 7; Fig. 
6b). The tension and FI for 4 and 10 Hz stimulations were both being markedly different 
from that of a 40 Hz stimulation (Fig. 6a and Fig. 6b). Consistent with observations of blood 
flow and vascular conductance, a 10 Hz stimulation frequency was chosen as the optimal 
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stimulation frequency to use, in assaying the differences between angiogenic treatment 
groups, maximising the chances of observing a significant effect. 
 
 
Fig 6: EDL tension and fatigue index during isometric muscle contraction. 
A-B show mean (±S.E.M. error bars, n = 7) EDL tension (initial and end) and fatigue index for 4, 10 and 40 Hz 
stimulations of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions achieved by indirect 
supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. 
* P < 0.01 vs. ‘initial’ (Student’s t-test). # P < 0.05 vs. other stimulation bouts (between treatments ANOVA 
with Scheffé Post hoc test). 
 
 
Other useful points from preliminary experiments included: deciding to fix the animal more 
securely using hindlimb clamps to eliminate movement upon stimulation, caring for isolated 
tissue (handled as carefully as possible to avoid trauma and kept bathed in physiological 
saline so as not to dehydrate or change pH), and deciding on an adequate time post-surgery 
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for baseline levels, of blood flow in particular, to return (~ 1 h). Blood flow measurement 
was increased from unilateral measurement to bilateral measurement at this point. 
 
The above studies allowed us to decide on the final protocol to follow; a typical LabChart 
trace from such a setup is shown (Fig. 7). 
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Fig 7: Raw trace from LabChart, for a final protocol experiment, with close-up of isometric tension generated. 
Top panel: A trace for a 10 Hz stimulation of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. 
Contractions achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min 
[indicated by the black bar]) of the cut common peroneal nerve. The ten channels show the continuous, real-time 
measurement of the labelled variables. Notice the absence of a central response in HR (channel 3), the smooth 
decay in tension generated (channel 5) and the bilateral asymmetry in FBF and FVC response to stimulation. 
The ipsilateral channels (channels 4, 6 & 7) show hyperaemia due to femoral artery vasodilatation, while 
contralateral channels (channels 8, 9 & 10) show no change in blood flow or femoral artery tone. The tension 
generated during the 5 minute stimulation period, was used to calculate a score of muscle fatiguability that could 
later be compared across animal treatment groups. Bottom panel: An unaltered close-up of the tension generated 
for a 10 Hz stimulation. 
 
4 - Ipsi FBF (ml min-1) 
 
5 - Ipsi Tension (g) 
 
1 - ABP (mmHg) 
2 - MABP (mmHg) 
3 - HR (BPM) 
 
6 - Ipsi MFBF (ml min-1) 
7 - Ipsi FVC  
     (ml min-1 mmHg-1) 
8 - Contra FBF (ml min-1) 
9 - Contra MFBF (ml min-1) 
10 - Contra FVC  
     (ml min-1 mmHg-1) 
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MATERIALS AND METHODS 
 
ANIMALS AND EXPERIMENTAL DESIGN: 
 
Overview 
Male Wistar rats were housed under Home Office regulations in the Biomedical Services 
Unit, University of Birmingham and were provided with standard chow and drinking water 
ad libitum. Animals were maintained at 20°C on a 12-hour light/ 12-hour dark cycle. Animals 
were assigned to one of four groups: 
 
Group 1 (n = 6) – Untreated body-weight matched controls, 
Group 2 (n = 6) – Administered with prazosin (50 mg L-1) in drinking water for 2 weeks, 
Group 3 (n = 5) – Unilateral surgical extirpation of TA, with post-operative recovery for 2 
weeks, 
Group 4 (n = 6) – Combinational treatment; unilateral surgical extirpation of TA, with post-
operative recovery for 2 weeks & administered with prazosin (50 mg L-1) in drinking water 
for 2 weeks (i.e. both Group 2 & 3 treatments; concurrently). 
 
All surgical interventions were performed in accordance with UK legislation (Home Office 
Animals (Scientific Procedures) Act 1986). Animals were taken into final, terminal 
experimentation when average body weight was 327 ± 7 g (mean ± S.E.M.). Body weights 
were approximately constant across each of the treatment groups, with the exception of 
combination treated animals, who were significantly lighter than extirpated animals (P < 0.05 
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vs. ‘extirpated’, between treatments ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 
respectively; Fig. 8). As combination treated animals were of the same body weight as both 
control animals and prazosin treated animals, their body weight was not of concern. The 
healthy body weight across treatment groups suggests that the treatments were not having a 
detrimental effect on animal health, and thus animals were healthy going into terminal in vivo 
experiments. 
 
 
Fig 8: Animal body weights going into terminal in vivo experiments. 
Mean body weight (±S.E.M. error bars) for each of the treatment groups (n = 6, 6, 5 and 6 respectively) going 
into terminal in vivo experiments. * P < 0.05 vs. ‘extirpated’ (between groups ANOVA with Scheffé Post hoc 
test). 
 
 
Advance preparation 
Group 2 animals were administered with 50 mg L-1 prazosin hydrochloride (Fluka Analytical, 
81515, Sigma-Aldrich) gradually dissolved overnight in distilled water, with a pinch of 
sucrose (Sigma-Aldrich) to mask the bitter taste and maintain consumption. This was 
provided ad libitum as drinking water for 2 weeks. Previous studies have shown that this 
regime induces elevated shear stress and shear-induced angiogenesis (Egginton et al. 2001; 
Hudlicka, Brown, Egginton 1992; Zhou et al. 1998a). 
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Group 3 animals underwent unilateral surgical extirpation of the ipsilateral (right) TA (see 
‘Surgical preparation for terminal experiments’ below), under Isoflurane inhalation 
anaesthesia (3.5% in Oxygen; Merial). Animals were treated perioperatively with systemic 
analgesic (2.5 ml kg-1 buprenorphine, subcutaneous (s.c.), Temgesic, National Veterinary 
Services) and topical antibiotic (Duplocillin LA, National Veterinary Services). Animals 
were carefully monitored for signs of pain or discomfort during the 2 week recovery period 
(locomotion recovers within days – hanging on cage bars – not having a detrimental effect on 
behaviour (Hudlicka, Brown, Egginton 1992)). Previous studies have demonstrated that this 
regime causes overload of the EDL and overload-induced angiogenesis (Egginton et al. 2001; 
Hudlicka, Brown, Egginton 1992; Zhou et al. 1998b). 
 
Group 4 animals were treated with a combination of the treatments in Groups 2 & 3. Surgical 
extirpation was performed and during the 2 week recovery period from surgery, prazosin was 
also administered in drinking water (started one day post-surgery to avoid excessive 
bleeding). 
 
 
EXPERIMENTAL PROTOCOL: 
 
 
Surgical preparation for terminal experiments 
Anaesthesia was induced with the inhalation anaesthetic Isoflurane (3.5% in O2), using an 
anaesthetic trolley (013406, General Anaesthetic Services; Harvard Apparatus Veterinary 
Fluosorber) and was judged to be at an adequate surgical level when the pedal withdrawal 
reflex was absent. The animal was fixed supine on a homeothermic heating blanket 
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positioned on a board, its forelimbs taped in place using micropore tape. Upon cannulation of 
the right jugular vein (Portex Translucent PVC Tubing, 0.63 mm ID, 1.40 mm OD), 
anaesthesia was maintained at a surgical level with continuous infusion of the steroid 
anaesthetic Alfaxan (9 mg ml−1 Alfaxalone diluted with physiological saline (0.9%) to 4 mg 
ml−1, infused at 12-20 mg kg−1 h−1 intravenous (i.v.); Vétoquinol, UK) using a Perfusor 
Device (Perfusor Secura FT, B.Braun (50 ml)); experiments were performed thereafter under 
this anaesthetic. Animals were allowed to breathe spontaneously via a tracheal cannula 
(stainless steel), helping to maintain airway patency. The left brachial artery was cannulated 
(Portex Fine Bore Polythene Tubing, 0.40 mm ID, 0.80 mm OD), to monitor systemic arterial 
blood pressure via a blood pressure transducer (MLT844, ADInstruments); the cannula was 
filled with heparinised (Heparin (mucous), LEO) saline (in 0.9% NaCl (Sigma-Aldrich)) to 
prevent blood clotting. A rectal probe was applied to the animal, which works by feedback 
with the underlying homeothermic heating blanket (Harvard Apparatus) to maintain animal 
body temperature at 37°C, as body temperature homeostasis is poorly maintained under 
anaesthesia. Bilaterally, a single incision through the skin and blunt dissection through the 
underlying connective tissue was made to allow isolation of the femoral artery from 
surrounding tissue, particularly below the inguinal ligament and around the circumflex 
branch. Surgical suture was inserted through the overlying muscle and skin was used to pull 
this tissue away from the incision, using retractors, for ease of access. The ipsilateral (right) 
common peroneal nerve was located in a ‘key-hole surgery’ manner, freed from the 
connective tissue by blunt dissection. A length of 6-0 surgical suture was tied around the 
proximal end of the nerve and the nerve cut on the proximal side of this tie; this region was 
kept hydrated by the application of physiological saline (0.9% NaCl) to tissue paper placed 
over the incision. Lastly, a single incision using a scalpel blade was made along the length of 
the ipsilateral (right) hindlimb, through the skin and underlying tissue, revealing the hindlimb 
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muscle. Blunt dissection was used to isolate the TA (unless already surgically removed 2 
weeks before; groups 3 & 4), and a scalpel to cut the tendon around the ankle joint. Blunt 
dissection was again employed to free the TA from the connective tissue between the TA and 
EDL, and holding the tendon tightly with forceps, a single cut of the scalpel blade used to 
remove the TA at its proximal end, along the plane of the neurovascular bundle. When 
performed effectively little bleeding occurred. The EDL was isolated in a similar manner and 
a double throw of 4-0 length of surgical suture looped around the tendon knotted tightly in 
place; the other end of the suture was used to attach the muscle to the force transducer. The 
EDL was also kept bathed in physiological saline, to avoid dehydration. 
 
Positioning the animal for experimental protocol 
Once surgery was completed, both hindlimbs were secured in place using paw clamps, taking 
care not to pull the hindlimbs too far out of place, thus restricting blood flow. Surgical suture 
was looped around the incisors and taped tightly to keep the animal as straight as possible; 
the tail base was similarly taped to keep the animal stretched out. The blood pressure 
transducer was calibrated with known pressure using a sphygmomanometer and the brachial 
artery cannula connected, avoiding the introduction of air bubbles. Two perivascular flow 
probes (0.7V; Transonic Systems Inc.), pre-calibrated with known flow and connected to a 
flow meter (T206, small animal blood flow meter; Transonic Systems Inc.), were placed 
around the femoral arteries for continuous measurement of FBF as an index of hindlimb 
blood flow. The suture tied around the EDL tendon was attached to a pre-calibrated, 
isometric force transducer (MLT1030/A, 1030/465, ADInstruments) to record tension 
developed in response to stimulation. Finally, using the suture tied around the sectioned 
common peroneal nerve, the nerve was positioned (without stretching it) so that a bipolar 
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silver electrode, connected to a Stimulator Unit (Grass Instruments, S8 stimulator) could be 
positioned beneath, to allow stimulation of the muscle. 
 
The blood pressure transducer was connected to a QUADBridge Bridge Amplifier (ML110, 
ADInstruments), the force transducer to a Bridge Pod (ML301, ADInstruments) and the flow 
probes, were all connected to the PowerLab hardware (4/30, ML118, ADInstruments) linked 
to an Apple Power PC G5 computer. Data was collected via LabChart software (v5.5, 
ADInstruments), to give a continuous real-time record of each of the variables. A ten channel 
settings file was designed to do so, including raw ABP, MABP, HR from the pulsatile ABP 
trace, raw ipsilateral and contralateral FBF traces, mean derivations of each (MFBF), 
ipsilateral and contralateral FVC (derived online by dividing MFBF by MABP) and 
ipsilateral EDL tension. 
 
Once all inputs were in place, the outputs on screen could be monitored. Using the tension 
trace, the optimal muscle length and stimulation voltage could be determined. By lengthening 
and shortening the muscle by moving the force transducer with a vernier clamp (making sure 
to keep it in plane) and stimulating the nerve, the length that produced maximal EDL twitch 
could be established. This was achieved by using a supramaximal stimulation voltage (around 
10 V). Once the preparation was set ready for stimulation, the preparation was allowed to rest 
and stabilise, for at least 1 h, before stimulation began. The depth of anaesthesia was checked 
regularly via either the corneal reflex, the palpebral reflex or by pinching the ear or tail (the 
pedal reflex could not now be used effectively as the hindlimbs were secured in clamps) and 
the general health of the animal was indicated by the cardiovascular variables monitored. 
 
The overall completed setup is summarised in Fig. 9 and Fig. 10. 
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Fig 9: Schematic showing experimental setup.  
 
The supine animal was secured in place by suture, tape and clamps. Anaesthesia was maintained continuously 
via a venous cannula. MABP was measured and HR derived via an arterial cannula. Bilateral MFBF was 
measured via perivascular flow probes and FVC calculated by MFBF/MABP. The isolated common peroneal 
nerve, cut at the proximal end, was stimulated electrically by an electrode, eliciting EDL muscle contraction. 
The EDL muscle was sectioned at the distal end and tied tightly to a force transmitter, to which it transmitted the 
muscle tension. The animal’s body temperature was maintained at 37°C using feedback control between the 
rectal temperature probe and the homeostatic heating blanket on which the animal was positioned.   
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Fig 10: Photographs showing the overall setup. 
 
Top panel, shows an overview of the completed setup. Bottom panel, shows a close up of the isolated common 
peroneal nerve (cut at the proximal end) with electrode positioned in place (A) and the EDL muscle (sectioned 
at the distal end) attached to the force transducer (B), in the natural plane of the muscle, and set at the 
determined optimal length; the flow probe positioned around the femoral artery is also shown (C). When the 
preparation was given sufficient time to recover and for baseline values to be restored, stimulation would 
commence.  
 
 
(A) 
(C) 
(B) 
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In vivo measurement of hindlimb blood flow, muscle tension and fatigue 
Once adequate time had been given for the preparation to obtain resting baseline levels, the 
stimulation began. Keeping the muscle moist, but ensuring the nerve was dry, contractions 
were evoked from rest. Indirect stimulation was applied (0.3 ms square-wave pulse width and 
supramaximal voltage, usually ~10 V) for a 5 min period, at a stimulation frequency of 10 
Hz. This frequency was shown to elicit maximal MFBF in preliminary experiments. Due to 
the earlier setting of the muscle, isometric twitch contractions were stimulated with a 
supramaximal voltage at this frequency, when the muscle was of optimal length, with no 
indication of a change in muscle length. A rest period was allowed at the end of the 
stimulation to allow baseline values to return. 
 
 
Blood gas analysis 
When the blood gas analyser was available (n = 6), arterial blood samples were taken from 
the left brachial artery cannula. Typically 120 µl was sampled using a capillary collection 
tube. Samples were analysed (IL-682, GEM Premier 4000, Instrumentation Laboratory) for 
blood gases and electrolytes. Blood was typically sampled at rest, and 30 s after muscle 
stimulation. 
 
 
Study caveat 
Once the 10 Hz stimulation was complete in each animal (including a 1 h rest period for 
baselines to be restored) but before the muscle was sampled and the experiment 
terminated, an additional 40 Hz stimulation was performed, in exactly the same way as 
that for a 10 Hz stimulation. This was done purely out of interest, to see whether any 
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potential changes revealed by a 10 Hz stimulation were also evident for a 40 Hz 
stimulation, or whether adaptations were intensity specific.  
 
 
Sampling of muscle 
Once the stimulation protocol was completed, the EDL was removed from both hindlimbs 
and weighed. A piece from the middle belly of the muscle was removed using a fine, sharp 
razor blade (Wilkinson Sword), mounted on a cork section in OCT Embedding Matrix 
(Raymond-Lamb) and rapidly frozen in isopentane pre-cooled in liquid nitrogen. The top and 
tail of the muscle were placed in Eppendorf tubes and frozen in liquid nitrogen. Samples were 
stored at -80°C for later histological studies. 
 
Experiment termination 
At the end of the experiment, all animals were terminated by overdose of the sodium 
pentobarbital anaesthetic, Euthatal (Merial); death was confirmed by cervical dislocation. 
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TISSUE HISTOLOGY – SECTIONING, STAINING AND COUNTING: 
 
Muscle sections (10 µm) were cut from frozen muscle samples, stored at -80°C, using a 
clinical cryostat (Clinicut) at -25°C. Cut sections were applied to Polylysine microscope 
slides (631-0107, VWR International) and checked for quality using an Olympus BH-2 Light 
Microscope. Muscle sections were allowed to dry at room temperature (~25°C), ringed with a 
wax pen (Vector Laboratories, UK) and fixed in 4% paraformaldehyde (TAAB Laboratories) 
for 1 min. Once washed with phosphate buffered saline (PBS) (Sigma-Aldrich), muscle 
sections were incubated with Lectin (Fluorescein conjugated Griffonia (Bandeiraea) 
simplicifolia Lectin, FL-1101, Vector Laboratories, UK) for 1 h at room temperature to mark 
ECs, washed again with PBS, stained with DAPI (Vectashield Mounting Medium with DAPI, 
H-1200, Vector Laboratories, UK) to identify nuclei, covered with cover glass and 
immediately imaged to prevent fluorescence quenching. 
 
Sections were imaged using a Zeiss Photomicroscope III and computer with AxioVision4 
software, at x20 magnification. Four sampling frames were obtained from each section, 
spread equally across the section; a calibrated scale bar was applied to each image (Fig. 11).  
 
Capillary and fibre counts were performed on each sampling frame offline, using an unbiased 
counting method consisting of inclusion and exclusion lines, explained in (Egginton 1990). 
Such counts were performed using ImageJ (v1.440) (Fig. 11). 
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Fig 11: Performing capillary and muscle fibre counts on a stained muscle section using ImageJ. 
 
The top panel shows an example image of a sampling frame across a muscle section. Lectin (green) stained 
endothelium and DAPI (blue) stained nuclei images have been overlayed. A 200 µm, pre-calibrated scale bar 
has been applied to the image to aid the calculation of capillary densities and mean fibre areas. The bottom 
panel illustrates the unbiased process by which capillary and muscle fibres counts were performed on a muscle 
section using ImageJ. The cell counter function was used to mark individual components, counter 1 for 
capillaries and counter 2 for muscle fibres. The top and right adjacent sides of the counting frame (indicated by 
the dashed red lines) were the inclusion lines, so components touching these lines were included. The bottom 
and left adjacent sides of the counting frame (indicated by the solid red lines) were the exclusions lines, so 
component touching these lines were excluded. This ensures that only components that lie entirely within the 
designated sampling frame are counted, giving the best unbiased estimate. 
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DATA ANALYSIS: 
 
All subsequent analysis was performed offline. 
 
Analysis set 1 – Gross response 
The DataPad function of LabChart was used to analyse the gross response to muscle 
stimulation. Mean MABP, mean HR, ipsilateral & contralateral MFBF, mean ipsilateral & 
contralateral FVC and (cyclic maximum – cyclic minimum) ipsilateral tension for 30 s time 
periods (baseline pre-stimulation, initial 30 s, end 30 s of stimulation, immediate 30 s post-
stimulation and baseline post-stimulation, up to 1 h later) were acquired. Fatiguability during 
the 5 min stimulation was expressed as FI by the ratio of end developed cyclic maximum 
tension to initial developed cyclic maximum tension (shown in Fig. 12). 
 
Fig 12: Calculating FI from tension traces. 
A diagram showing two overlayed, unmanipulated tension traces (for EDL muscle of prazosin treated animal in 
grey and EDL muscle of combination treated animal in black) from LabChart. The isometric tension generated 
by supramaximal 10 Hz stimulation, decays over the 5 minute stimulation period. FI is calculated by expressing 
the mean cyclic maximum tension between the initial 30 s and end 30 s of stimulation (indicated by red dashed 
boxes) as a ratio [end/ initial]. In this instance there appears to be a difference in FI between these two 
differently treated groups of animals, suggesting a treatment effect.  
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Analysis set 2 – Twitch characteristics 
The DataPad function of LabChart was used in conjunction with the PeakParameters plugin. 
The rise time and fall time (defined as the time taken to rise from 25% to 75% of the twitch 
peak from baseline and the time taken to fall from 75% to 25% of the twitch peak to 
baseline, when baseline is set by the user; shown in Fig. 13) for five successive twitches at 
the absolute peak of a contraction and five equal-amplitude successive twitches in the final 
10 s of a contraction, were acquired. For each twitch, the ‘baseline’ was set as the initial 20 
ms of baseline before an individual twitch was evoked. Each of the five successive twitches 
were averaged, before comparison was made between treatment groups.  
 
 
Fig 13: The peak parameters window used to derive twitch rise and fall times. 
 
For a 10 Hz stimulation, the initial 20 ms of the window was set as the baseline, indicated to the left of the 
black dot set in the red circle. This point was set as the baseline relative to the absolute twitch peak 
(automatically detected). The lines indicated by arrows at the first and third quartile were the limits between 
which the rise and fall times were calculated. 
 
 
 
Rise 
Time 
Fall 
Time 
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Analysis set 3 – Half relaxation tension and time 
For each muscle tension profile generated by stimulation, the ‘absolute peak’ tension and 
‘end’ tension were recorded and the specific half relaxation tension (N) was calculated (i.e. 
0.5 x [‘absolute peak’ tension – ‘end’ tension]). The time into the stimulation period at 
which this decay in tension was achieved was recorded to give the specific half relaxation 
time (s). 
 
Analysis set 4 – Muscle histology 
Capillary and fibre counts, once performed on each sampling frame (four across each muscle 
section), were averaged for one muscle section for the EDL (ipsilateral and contralateral 
muscles for extirpated animals and combination treated animals only) of every animal. Such 
counts were expressed as C:F ratio (by simple division) and CD (µm-2) and MFA (µm2) by 
using the scale bar to calibrate pixels to section area. Data was then compared between 
muscles (both between ipsilateral muscles only and between ipsilateral and contraclateral 
muscles where the two muscles within the same animal had been differentially treated) in 
each treatment group. 
 
Where appropriate, data were normalised and expressed per unit muscle weight. All graphs 
were produced using DeltaGraph (v5.7.5, SPSS Inc., Red Rock Software). 
 
 
STATISTICAL ANALYSIS: 
 
All data are presented as means ± S.E.M. error bars, with numbers of animals (n) given in 
parentheses. 
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Differences between treatment groups (i.e. for functional data [MABP, HR, MFBF, FVC, 
tension and calculated FI, rise and fall times & half relaxation tension and time] at a specific 
time point for ipsilateral muscles; for structural data [muscle weights, C:F ratio, CD & MFA] 
of ipsilateral muscles) were determined by between treatments ANOVA with Scheffé post 
hoc test where appropriate. When a pair-wise comparison was desired (i.e. for functional data 
[tension ‘initially’ and ‘at end’] for a particular muscle contraction; for structural data 
[muscle weights, C:F ratio, CD & MFA] between ipsilateral and contralateral muscles within 
the same treatment group), data were compared using Student's t-test. Differences within 
treatment groups across a time course (i.e. for functional data [MABP, HR, MFBF & FVC 
profile in time] within ipsilateral muscles) were determined by within treatments ANOVA for 
repeated measures, with Scheffé post hoc test where appropriate. All statistical analysis was 
performed using Aabel3 (20/20 Data Vision, Gigawiz). Statistical significance was set at P < 
0.05. 
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RESULTS 
 
The data that makes up the figures in this chapter are from completely different 
animals to that in the Method Development chapter, using the refined final protocol 
described in the Materials and Methods chapter. The ‘Study caveat’ data is described 
here but the figures related to the ‘Study caveat’ are included in the Appendix. 
 
 
Did the angiogenic stimuli induce angiogenesis? 
Two week prazosin administration is known to induce splitting angiogenesis in EDL muscle, 
resulting in an increase in C:F ratio (Zhou et al. 1998a). Unfortunately, there was not an 
increase in C:F ratio observed in our prazosin treated animals (ns, between groups ANOVA 
with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 21a), suggesting it is unlikely 
that any splitting angiogenesis was successfully induced. However our prazosin treated 
animals had elevated femoral artery blood flow relative to both control animals and 
extirpated animals (P < 0.05 vs. ‘control’ and ‘extirpated’, between groups ANOVA with 
Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 14a), suggesting there was perhaps a 
partial effect on the endothelium. 
 
Two week recovery from surgical extirpation of the TA muscle is known to induce sprouting 
angiogenesis in EDL muscle, resulting in compensatory muscle hypertrophy in the ipsilateral 
muscle relative to the contralateral muscle (by around 20%), with an approximately parallel 
increase in C:F ratio (Egginton et al. 1998; Zhou et al. 1998b). Fortunately, this was the case 
in our extirpated animals (P < 0.05 vs. ‘contralateral’, Student’s t-test, n = 6; Table. 1) and (P 
< 0.05 vs. ‘contralateral’, Student’s t-test, n = 6; Fig. 21a), suggesting that sprouting 
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angiogenesis was successfully induced. Compensatory muscle hypertrophy was induced in 
the ipsilateral muscles of both extirpated animals and combination treated animals, relative to 
their contralateral muscles by approximately 22% and 34% respectively. Interestingly the 
ipsilateral muscle of the combination treated animals experienced a higher degree of 
hypertrophy than the ipsilateral muscle of the extirpated animals (P < 0.05 vs. ‘extirpated % 
change’, Student’s t-test, n = 6; Table. 1). 
 
 
Table 1: EDL muscle weights across the treatment groups. 
 
Tabulated individual animal EDL muscle weights for each of the four treatment groups (n = 6), including both 
ipsilateral and contralateral muscle weights for extirpated animals and combination treated animals. Mean data 
and S.E.M. have been calculated. * P < 0.05 vs. ‘contralateral’ (Student’s t-test). ^ P < 0.05 vs. ‘extirpated % 
change’ (Student’s t-test). 
 
 
    
Extirpated 
 
Combination 
Rat # Control Prazosin 
 
Ipsi Contra 
% 
Change 
 
Ipsi Contra 
% 
Change 
 
1 141.4 155.6 
 
203.4 161.7 25.8 
 
174.9 141.1 24.0 
2 133.3 161.9 
 
255.0 210.9 20.9 
 
236.8 167.5 41.4 
3 133.2 173.2 
 
217.4 175.9 23.6 
 
191.8 155.7 23.2 
4 156.3 129.3 
 
219.5 153.1 43.4 
 
187.2 117.3 59.6 
5 176.7 173.3 
 
162.0 148.9 8.8 
 
147.8 113.3 30.5 
6 172.1 164.8 
 
175.1 158.9 10.2 
 
162.0 127.3 27.3 
           
Mean 152.2 159.7 
 
 
205.4 168.2 22.1 
 
183.4 137.0 34.3 
    
* 
   
* 
 
^ 
S.E.M. 7.8 6.7 
 
13.7 9.3 5.1 
 
12.6 8.8 5.7 
            
 
As one stimuli was apparently induced and the other was not, it is bought into question 
whether two angiogenic stimuli were actually been applied in combination treated animals. 
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Effect of stimulation on blood flow 
During the 10 Hz stimulation, there was no discernible central response in MABP or HR 
regardless of treatment group (ns, within groups ANOVA for repeated measures, with 
Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; data not shown), showing both the 
efficiency of motor nerve transection and that the localised responses to altered blood flow 
had little effect on systemic cardiovascular variables (thus, there was little difference whether 
muscle perfusion was measured as blood flow or vascular conductance). The functional 
hyperaemia associated with muscle activity was significant by the ‘end’ of the 5 minute 
stimulation for all treatment groups (P < 0.05 vs. ‘rest’, within subjects ANOVA for repeated 
measures, with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 14a). Relative blood 
flow was significantly increased in prazosin treated animals at ‘rest’, ‘initially’ and at the 
‘end’ of contractions (P < 0.05 vs. ‘control’ and ‘extirpated’, between groups ANOVA with 
Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 14), but no different to that in 
combination treated animals. Contralateral blood flow was unaffected, showing no evidence 
for a bilateral steal effect, during ipsilateral stimulation (ns, within groups ANOVA for 
repeated measures, with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; data not shown). 
The functional hyperaemia profile observed as stimulation progressed remained in proportion 
across each of these treatment groups, i.e. no shift in the gradient at which blood flow 
changed across the treatment groups. Values returning to baseline levels at ‘rest’, around 1 h 
later. 
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Fig 14: Vascular response during 10 Hz isometric contraction of EDL muscle. 
A-B show mean (±S.E.M. error bars) MFBF and FVC for control, prazosin, extirpated and combination animals 
(n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL muscle, at 5 different time points, in Alfaxan-
anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation (0.3 ms square-
wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. * P < 0.05 vs. ‘rest’ (within groups 
ANOVA with Scheffé Post hoc test). # P < 0.05 vs. ‘control’ and $ P < 0.05 vs. ‘prazosin’ (between groups 
ANOVA with Scheffé Post hoc test). 
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Developed muscle tension and fatigue index 
When the gross response to muscle contraction was assessed, the muscle tension and FI 
derived were consistent, indicating a stable preparation and a robust sampling regime. 
Furthermore the decay profile was as expected for the EDL, stimulated at this frequency. For 
all treatment groups there was a significant decay in tension by the ‘end’ of the stimulation 
period, (P<0.05 vs. ‘initial’, Student’s t-test, n = 6, 6, 5 & 6 respectively; Fig. 15a). There 
was no treatment effect between the groups on ‘initial’ tension generated (ns, between groups 
ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 15a). There was 
however a tendency for extirpated animals and combination treated animals to have an 
increased ‘end’ tension generated, (although ns, between groups ANOVA with Scheffé Post 
hoc test, n = 6, 6, 5 & 6 respectively; Fig. 15a). This did however lead to a significantly 
increased FI for extirpated animals (P < 0.05 vs. ‘control’ and ‘prazosin’, between groups 
ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 15b). This indicates 
that the muscle in extirpated animals had a significantly decreased fatiguability, relative to 
the muscle in both control animals and prazosin treated animals, though no such change was 
seen for the muscle in combination treated animals. Specific tension, allowing for significant 
variation in muscle mass among groups, suggested a slight weakening of the EDL following 
extirpation, with or without prazosin administration (Fig. 16). 
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Fig 15: EDL tension and fatigue index during 10 Hz isometric muscle contraction. 
A-B show initial and end mean (±S.E.M. error bars) EDL tension and overall fatigue index for control, prazosin, 
extirpated and combination animals (n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL muscle, in 
Alfaxan-anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation (0.3 ms 
square-wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. * P < 0.05 vs. ‘initial’ (Student’s t-
test). # P < 0.05 vs. ‘control’ and $ P < 0.05 vs. ‘prazosin’ (between groups ANOVA with Scheffé Post hoc 
test). 
 
 
Fig 16: Specific EDL tension during 10 Hz isometric twitch contraction. 
Graph shows the initial and end mean (±S.E.M. error bars) EDL tension, normalised for EDL muscle weight to 
allow for variation between groups, for control, prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 
respectively) upon stimulation of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions 
achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut 
common peroneal nerve. * P < 0.05 vs. ‘initial’ (Student’s t-test). 
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Investigation of muscle characteristics 
Analysis of tension decay for a 10 Hz stimulation, consistent with the derived FI, indicated 
that the developed half relaxation muscle tension was not changed between treatment groups 
(ns, between groups ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 
17a), however the time taken to reach the half relaxation muscle tension (the half relaxation 
time) was significantly increased in extirpated animals (P < 0.05 vs. ‘control’ and ‘prazosin’, 
between groups ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 17b) 
but not in combination treated animals (P < 0.05 vs. ‘extirpated’, between groups ANOVA 
with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 17b). This suggests that the 
muscle tension in extirpated animals decays to approximately an equal half relaxation tension 
to that in the other treatment groups, but takes a significantly longer period of time to reach 
that tension (the half relaxation time). This decrease in fatiguability is lost in the muscle of 
combination treated animals, like it is for FI. At 10 Hz, the twitch rise time and fall times 
were unaffected by treatment, either ‘initially’ or at the ‘end’ of stimulation (ns, between 
groups ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. 18). 
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Fig 17: Half relaxation properties of EDL muscle undergoing a 10 Hz isometric twitch contraction. 
A-B show mean (±S.E.M. error bars) EDL muscle half relaxation tension and half relaxation time for control, 
prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL 
muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation 
(0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. * P < 0.05 vs. ‘control’, # P 
< 0.05 vs. ‘prazosin’ and $ P < 0.05 vs. ‘extirpated’ (between groups ANOVA with Scheffé Post hoc test). 
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Fig 18: Muscle twitch rise time and fall times, for EDL muscle undergoing 10 Hz isometric twitch contraction. 
A-B show mean (±S.E.M. error bars) individual EDL muscle twitch rise time and fall times, initially and at the 
end of the stimulation period, for control, prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 
respectively) upon stimulation of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions 
achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut 
common peroneal nerve. There was no significant difference in either rise time or fall times between group 
during the initial or end period of the bout of contraction. 
 
 
 
Blood chemistry 
No change was seen in any blood gas component post-stimulation (ns, within subjects 
ANOVA for repeated measures, with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; data 
not shown), suggesting muscle stimulation produced a largely local, not systemic response. 
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Study caveat 
(For figures see Appendix). 
The additional 40 Hz stimulation, when analysed, yielded similar data to that of a 10 Hz 
stimulation, at least for blood flow data. The functional hyperaemia associated with 
muscle activity was again significant by the ‘end’ of the 5 minute stimulation for all 
treatment groups (P < 0.05 vs. ‘rest’, within subjects ANOVA for repeated measures, 
with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. A1a). Again, relative blood 
flow was significantly increased in prazosin treated animals at ‘rest’, ‘initially’ and at 
the ‘end’ of contractions (P < 0.05 vs. ‘control’ and ‘extirpated’, between groups 
ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. A1), but no 
different to that in combination treated animals. As seen for a 10 Hz stimulation, for all 
treatment groups there was a significant decay in tension by the ‘end’ of the stimulation 
period, (P < 0.01 vs. ‘initial’, Student’s t-test, n = 6, 6, 5 & 6 respectively; Fig. A2a). 
However, converse to a 10 Hz stimulation, there was no treatment effect between the 
groups for neither ‘initial’ or ‘end’ tension generated, meaning there was no significant 
change in FI (all ns, between groups ANOVA with Scheffé Post hoc test, n = 6, 6, 5 & 6 
respectively; Fig. A2a&b). Specific tension, again suggested a tendency for slight 
weakening of the EDL following extirpation, with or without prazosin administration 
(Fig. A3). The developed half relaxation muscle tension and time were not changed 
between treatment groups (ns, between groups ANOVA with Scheffé Post hoc test, n = 
6, 6, 5 & 6 respectively; Fig. A4a&b), highlighting another difference to that of the 10 
Hz stimulation. The twitch rise time and fall times were again unaffected by treatment, 
either ‘initially’ or at the ‘end’ of stimulation (ns, between groups ANOVA with Scheffé 
Post hoc test, n = 6, 6, 5 & 6 respectively; Fig. A5). 
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Muscle composition: capillaries and fibres 
 
Example photomicrographs of stained muscle sections for each of the treatment groups are 
included (Fig. 19) to give a visual representation of the scope of histological changes in 
muscle, from which counts were performed. 
 
Analysis of muscle section counts revealed a tendency for an increase in C:F ratio in muscle 
from prazosin treated animals, relative to control animals (though ns, between groups 
ANOVA with Scheffé Post hoc test, n = 6; Fig. 20a); however a significant increase in C:F 
ratio was seen in muscle from extirpated animals (P < 0.05 vs. ‘control’ and ‘prazosin’, 
between groups ANOVA with Scheffé Post hoc test, n = 6; Fig. 20a) and to a lesser extent in 
combination treated muscle (P < 0.05 vs. ‘control’, between groups ANOVA with Scheffé 
Post hoc test, n = 6; Fig. 20a). For both of these treatments, the increases in C:F ratio in 
ipsilateral muscles were significant relative to the contralateral muscles (P < 0.05 vs. 
‘contralateral’, Student’s t-test, n = 6; Fig. 20a) in the same animals (at levels 
indistinguishable from controls). CD data suggested a tendency for a decrease in muscles 
from prazosin treated animals relative to control animals, and an increase in ipsilateral 
muscles from extirpated animals, relative to control animals, however this wasn’t the case 
(ns, between groups ANOVA with Scheffé Post hoc test, n = 6; Fig. 20b). The only 
significant change for CD was highlighted between the ipsilateral and contralateral muscles 
of extirpated animals (P < 0.05, Student’s t-test, n = 6; Fig. 20b). MFA’s remained 
approximately constant regardless of treatment (ns, between groups ANOVA with Scheffé 
Post hoc test, n = 6; Fig. 20c), although contralateral muscles from combination treated 
animals had a tendency to have a decreased MFA, relative to all other treatment groups (Fig. 
20c). 
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Fig 19: EDL muscle photomicrographs. 
Photomicrographs show typical EDL muscle sections (at x20 magnification), stained for Lectin (Fluorescein 
conjugated Griffonia (Bandeiraea) simplicifolia Lectin), which were used to generate histological count data 
(C:F ratio, CD and MFA). For extirpated and combination animals, both the ipsilateral and contralateral EDL 
muscles were sampled and analysed, to show relative change. Four such photomicrographs across the section of 
each EDL muscle were averaged for each animal, before being compared to other animals in other treatment 
groups. Mean (±S.E.M.) C:F ratio, CD and MFA values for each treatment group (n = 6) are indicated. 
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Fig 20: Histological counts. 
A-C show mean (±S.E.M. error bars) C:F ratio, CD and MFA counts performed from stained EDL muscle 
sections sampled from control, prazosin treated, extirpated (ipsilateral and contralateral muscles) and 
combination treated (ipsilateral and contralateral muscles) animals (n = 6 for each). * P < 0.05 vs. ‘ipsilateral’ 
(Student’s t-test). # P < 0.05 vs. ‘control’ and $ P < 0.05 vs. ‘prazosin’ (between groups ANOVA with Scheffé 
Post hoc test). There was no significant difference in MFA between groups. 
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DISCUSSION 
 
The final setup and protocol implemented allowed us to collect quality data, in replicate, from 
which we were able to draw appropriate comparisons. 
 
Comparisons with the literature 
This study aimed to build on the work of others (Egginton et al. 2011), that showed certain 
physiological angiogenic stimuli caused angiogenesis in a graded, not threshold manner. 
Further, preliminary work by Olgaard et al. (2008) had indicated that when two 
fundamentally different stimuli, that were shown to evoke two different types of 
angiogenesis, were applied concurrently, no additive effect in C:F ratio was produced. 
Unfortunately, our data is confounded by the fact that the administration of prazosin didn’t 
seem to induce an increase in C:F ratio, like it does in the literature (Zhou et al. 1998a). 
Surgical extirpation however, did induce the expected increase in C:F ratio (Zhou et al. 
1998b). 
 
The functional hyperaemia responses observed during EDL muscle contraction were 
comparable to that seen in similar studies (Ray and Marshall 2009a; Ray and Marshall 
2009b), although slightly different to muscle blood flow data obtained using radioactive 
microspheres (Hargreaves, Egginton, Hudlicka 1990). The tension generated by EDL 
muscles, across the treatment groups, was also comparable to that achieved by others 
(Egginton et al. 1998; Fulgenzi et al. 1998; Ray and Marshall 2009a; Ray and Marshall 
2009b). 
 
P a g e  | 59 
 
Surgical extirpation of the TA, induced compensatory hypertrophy of the EDL after 2 weeks, 
to the same degree compared to contralateral muscles (≈ 20 %), to that seen in the literature 
(Egginton et al. 1998). A parallel increase in C:F ratio, relative to the contralateral muscle 
was also evident (Zhou et al. 1998b). Our study used a 10 Hz contraction to assay EDL 
performance as it was the stimulation frequency that produced the maximum blood flow; this 
was different to the 4 Hz used in the literature (chosen for the same reason) (Hawker and 
Egginton 1999). There was however, no significant difference in blood flow or tension 
generated, between the two frequencies in our preliminary experiments and so general 
comparisons could be made. Blood flow data was not different to that seen in controls, like 
that in the literature (Egginton et al. 1998). Similarly, the generated tension here, was no 
different to that in controls, agreeing with some literature (Egginton et al. 1998), but not 
others (Frischknecht and Vrbova 1991), although the length of treatment in our study was far 
less, so this was not surprising. The FI for a 4 Hz contraction did not differ from that in 
contralateral muscles after 2 weeks (Egginton et al. 1998). For a 10 Hz contraction however 
there was a significant improvement in the fatigue resistance relative to that seen in controls; 
it took 8 weeks of treatment for such significance to be seen at 4 Hz (Egginton et al. 1998). 
Furthermore here, the increased C:F ratio (in parallel with the increase in muscle weight) was 
aligned with the improved FI. It seems that the compensatory hypertrophy is responsible for 
the improvement in fatigue resistance. Although not assayed for, this was likely achieved 
through a shift in fibre phenotype, from type IIb glycolytic fibres towards type I oxidative 
fibres (Degens et al. 1992; Yamaguchi et al. 1996). Finally, it is evident that in muscle that 
has undergone compensatory hypertrophy (of the whole muscle – muscle hypertrophy), that 
the increased muscle mass is accounted for by fibre hyperplasia (Antonio and Gonyea 1993) 
and not because of fibre hypertrophy (James 1973), as indicated by the constant MFA across 
treatment groups.  
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Prazosin administration did not induce an increase in C:F ratio in EDL relative to controls, 
like that seen in the literature (Fulgenzi et al. 1998; Zhou et al. 1998a). Our study used a 10 
Hz contraction to assay EDL performance as it was the stimulation frequency that produced 
the maximum blood flow; this was different to the 4 Hz used in the literature (Fulgenzi et al. 
1998). This was a study investigating fatigue resistance in ischaemic muscle (for combined 
TA and EDL) and the benefits in muscle performance of prazosin administration (hence 
having a similar setup to our own and why data [untreated controls vs. prazosin treated; 
ischaemic data ignored] can be compared). Blood flow data was elevated in prazosin treated 
animals to that seen in controls, like that in the literature (Fulgenzi et al. 1998; Milkiewicz et 
al. 2001). The generated tension and calculated FI in our study was no different to that in 
controls, agreeing with what seen for combined TA and EDL in the ischaemic muscle study 
(Fulgenzi et al. 1998) and for EDL alone in a different study (Ziada et al. 1984). Finally, 
there was no change in MFA or fibre phenotype, relative to controls, which is as expected 
(Hudlicka, Brown, Egginton 1992). 
 
Data from combination treated animals was interesting as both the C:F ratio and FI (which 
are proportional) for their muscles had intermediate values to that seen for prazosin treated 
animals and extirpated animals (although these were not significant relative to controls, like 
extirpated animals were). This is intriguing as even though it seems that prazosin 
administration alone didn’t increase C:F ratio, there is a decrease in the C:F ratio and FI from 
that seen in animals treated with extirpation only, in the combination treated animals. Thus it 
seems that prazosin and/ or a downstream component of the splitting angiogenesis pathway is 
interacting with the sprouting angiogenesis pathway, preventing any additive effects and 
furthermore, reducing the normal effects induced by extirpation alone. It seems prazosin is 
having an effect on blood flow, but not the desired effect on capillary growth, that normally 
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follows the systemic hyperaemia! A further confounder is the huge compensatory 
hypertrophy seen in these animals (significantly larger than for extirpated animals!); for these 
animals there wasn’t a parallel relationship evident between muscle mass, C:F ratio and FI, 
like there was in extirpated animals. 
 
 
‘Additive angiogenesis’; not exactly additive! 
Although our data has been confounded by the reality that one of our stimuli has not induced 
capillary growth, it could be suggested, like in Olgaard et al. (2008), that additive 
angiogenesis of the two stimuli used in this study, cannot be seen in any of the structural or 
functional readouts we assayed. In Olgaard et al. (2008), the C:F ratio for ipsilateral muscle 
in extirpated animals and combination treated animals was constant, whereas this study has 
shown that the ipsilateral muscle C:F ratio in combination treated animals is in fact less than 
that in extirpated animals. This is certainly not an additive effect. Thus, it seems that for 
physiological angiogenesis, a given stimuli may well induce blood vessel growth in a graded 
manner (Egginton et al. 2011), but different stimuli cannot be applied concurrently to yield an 
additive effect. This may be because the net angiogenic stimuli present in these animals is 
‘excessive’ and supra-physiological. Thus, feedback regulation may be keeping angiogenic 
signalling under control, like an ‘angiogenic brake’. This putative component of angiogenic 
signalling is likely to be an endogenous angiogenesis inhibitor, similar in nature to (or 
actually) thrombospondin-1 (Olfert and Birot 2011). 
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Aligning structure and function  
Interestingly, when the range of C:F ratio’s across the treatment groups were correlated by 
means of a regression plot, with the range of FI’s for the 10 Hz stimulation, a trend emerges 
(r2 = 0.89; Fig. 21a). For example, in the muscle of extirpated animals, there was a 33% 
increase in C:F ratio compared to control muscle, correlating with a 28% increase in FI. This 
was not the case when FI was compared with the maximal ipsilateral vascular conductance, 
for a 10 Hz stimulation; no such correlation was discernible (r2 = 0.0046; Fig. 21b). These 
plots suggest that the fatiguability of the EDL is proportional to the C:F ratio of the muscle, 
rather than the net blood flow to the muscle; ergo the local capillary supply (local diffusive 
path length between capillary and muscle fibre) is more important than global perfusion (bulk 
flow to and from the capillary network), in determining fatigue resistance. This is in line with 
current thinking (Egginton and Gaffney 2010). 
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Fig 21: Alignment of structural and functional variables. 
A-B are regression plots (S.E.M. xy error bars) correlating mean C:F ratio (A) and mean maximal FVC (B) with 
mean FI for a 10 Hz stimulation, across all treatment groups (n = 6; defined by a coloured point: control, 
prazosin, extirpated and combination animals). A: r2 = 0.89; B: r2 = 0.0046. 
 
 
Study caveat 
The additional 40 Hz stimulation yielded data with no treatment specific effects. This 
may be because of insufficient rest time (typically 1 h) after the 10 Hz stimulation for 
baseline levels to be restored, before the next stimulation was initiated. Two hours is 
known to be sufficient time for glycogen repletion of fibres (Hudlicka et al. 1994); 
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perhaps because a full two hours wasn’t given for recovery, glycogen depleted fibres 
were more fatiguable, accounting for the lack of significance observed. 
 
Critique and improvements 
Should this in vivo setup and protocol be used again for future experiments, a number of 
improvements could be made. For example, it would be better if a specially designed board/ 
frame, as used by the group before (Hudlicka et al. 1994), was used to completely eradicate 
animal movement upon stimulation of the nerve. This would ensure the most accurate tension 
was recorded by the force transducer. Alternatively, the animal could be securely fixed by 
drilling pins into the femur and securing said pins rigidly in place (Egginton and Hudlicka 
1999). Methodological alterations would improve the quality and reliability of data obtained. 
Upon hindsight it is clear that bathing the muscle with room temperature saline, to avoid 
dehydration, wasn’t enough; 37°C saline would have been better to maintain muscle surface 
temperature as close to that of body temperature as possible. Mitochondrial enzymes, active 
during cellular respiration, work optimally at body temperature, so any deviation from the 
optimal temperature will yield sub-optimal data. Another significant alteration to the method 
that should be made is the use of a ‘water diary’. By recording the volume of water consumed 
by each animal, the exact prazosin dose required could be administered to each animal. This 
would have ensured sufficient dosing of those animals consuming prazosin, which may have 
resulted in a significant increase in C:F ratio in muscle of those animals, as seen in the 
literature! 
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Future directions 
Apart from perhaps repeating the study once prazosin administration was refinedm to obtain 
conclusive data, future direction should focus on obtaining genomic and proteomic readouts 
of key angiogenic signalling components (by qPCR and Western blotting respectively), from 
the frozen muscle sampled. Such data may indicate why the combinational therapy was less 
effective than either of the individual treatments and to what extent each is driving 
angiogenesis. The makeup of the putative ‘angiogenic brake’ would also be an interesting 
avenue to explore, a candidate being thrombospondin-1 (Olfert and Birot 2011), if it is indeed 
this that is inhibiting excessive signaling. It would be instructive to perform such a study, as it 
would complement the structural and functional data derived here by probing the extent of 
interaction among the angiogenic signalling pathways.  
 
Conclusion 
The key finding of this study was that muscle overload, but not elevated shear stress (possibly 
due to insufficient prazosin consumption by the animals), resulted in an increase in EDL C:F 
ratio, which was correlated with its increased fatigue resistance for a 10 Hz stimulation. 
Application of both of the two stimuli yielded a lesser response in both C:F ratio and fatigue 
resistance, than for muscle overload alone. This suggests, at this ‘level’ of overload (degree 
of surgical ablation)/ shear stress (dose of prazosin), that an additive effect is not possible, 
perhaps due to modulation by endogenous angiogenesis inhibitors (Fig. 22). Translation of 
physiological angiogenesis research into the clinic should aim at establishing minimal-effort 
exercise regimes that generate maximal health gains. 
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Fig 22: A much simplified schematic summarising the key points of this study. 
The mechanical stimuli explored in this study induce two different types of angiogenesis, via similar and 
different chemical components of the angiogenesis signalling network. In this case, prazosin administration did 
not yield a significant increase in EDL C:F ratio, relative to controls, unlike surgical extirpation which caused a 
significant increase in EDL C:F ratio. Combination treatment resulted in EDL C:F ratio between the two 
treatments individually, though not significant relative to controls. EDL C:F ratio correlated with improved 
fatigue resistance in ipsilateral muscle from extirpated animals and combination treated animals compared to 
controls, although no change in fatigue resistance was evident in muscle from prazosin treated animals. It is of 
interest, to what extent each angiogenic signalling pathway contributes to the change seen in combination 
treated animal muscle structure and function and the identity and molecular activity (hypothesised by inhibitory 
signs) of the putative feedback regulator that orchestrates the ‘angiogenic brake’. 
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APPENDIX 
 
Fig A1: Vascular response during 40 Hz isometric contraction of EDL muscle. 
A-B show mean (±S.E.M. error bars) MFBF and FVC for control, prazosin, extirpated and combination animals 
(n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL muscle, at 5 different time points, in Alfaxan-
anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation (0.3 ms square-
wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. * P < 0.05 vs. ‘rest’ (within groups 
ANOVA with Scheffé Post hoc test). # P < 0.05 vs. ‘control’ and $ P < 0.05 vs. ‘prazosin’ (between groups 
ANOVA with Scheffé Post hoc test). 
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Fig A2: EDL tension and fatigue index during 40 Hz isometric muscle contraction. 
A-B show initial and end mean (±S.E.M. error bars) EDL tension and overall fatigue index for control, prazosin, 
extirpated and combination animals (n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL muscle, in 
Alfaxan-anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation (0.3 ms 
square-wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. ** P < 0.01 vs. ‘initial’ (Student’s 
t-test). There was no significant difference in fatigue index between groups. 
 
 
Fig A3: Specific EDL tension during 40 Hz isometric twitch contraction. 
Graph shows the initial and end mean (±S.E.M. error bars) EDL tension, normalised for EDL muscle weight to 
allow for variation between groups, for control, prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 
respectively) upon stimulation of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions 
achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut 
common peroneal nerve. ** P < 0.01 vs. ‘initial’ (Student’s t-test). 
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Fig A4: Half relaxation properties of EDL muscle undergoing a 40 Hz isometric twitch contraction. 
A-B show mean (±S.E.M. error bars) EDL muscle half relaxation tension and half relaxation time for control, 
prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 respectively) upon stimulation of the EDL 
muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions achieved by indirect supramaximal stimulation 
(0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut common peroneal nerve. There was no significant 
difference in EDL muscle half relaxation tension or half relaxation time between groups. 
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Fig A5: Muscle twitch rise time and fall times, for EDL muscle undergoing 40 Hz isometric twitch contraction. 
A-B show mean (±S.E.M. error bars) individual EDL muscle twitch rise time and fall times, initially and at the 
end of the stimulation period, for control, prazosin, extirpated and combination animals (n = 6, 6, 5 and 6 
respectively) upon stimulation of the EDL muscle, in Alfaxan-anaesthetised male Wistar rats. Contractions 
achieved by indirect supramaximal stimulation (0.3 ms square-wave pulse width, ≈ 10 V, 5 min) of the cut 
common peroneal nerve. There was no significant difference in either rise time or fall times between group 
during the initial or end period of the bout of contraction. 
 
 
 
